Filing Details
- Accession Number:
- 0000805928-22-000105
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-08-08 17:49:51
- Reporting Period:
- 2022-08-04
- Accepted Time:
- 2022-08-08 17:49:51
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
805928 | Axogen Inc. | AXGN | Electromedical & Electrotherapeutic Apparatus (3845) | 411301878 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1492710 | Gene Gregory Freitag | 13631 Progress Blvd. Suite 400 Alachua FL 32615 | Yes | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2022-08-04 | 24,000 | $10.64 | 387,515 | No | 4 | S | Direct | |
Common Stock | Disposition | 2022-08-08 | 13,046 | $10.37 | 374,469 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- The sale reported on the this Form 4 was effected pursuant to a Rule 10b5-1 trading plan.
- The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $10.35 to $10.88 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
- The reported price in Colum 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging for $10.15 to $10.72 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote,